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Structure-based metabolic engineering 
and synthetic biology for efficient    
strain development 
An-Ping Zeng
Institute of Bioprocess and Biosystems Engineering
Hamburg University of Technology
Our research areas: 
1.Design of biocatalysts
2.Systems Biology / Modeling 
3.Integrated bioprocesses / Biorefinery
Present praxis of metabolic engineering 
and its limitation in strain development
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 Not efficient for protein-level limitation
Often Yes/No changes/lack of dynamic control
Mostly trial and error
Design and control of bioreactions at 
atomic level and from first principle
4
Make use of the potentials in structural biology 
and computing
World’s most brilliant X-ray and light sources 
for structural study at DESY/Hamburg
Beyond the static 
structure 
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Petra III European free-electron laser facilities
also „see“ 
dynamics 
at fs (10-15s)!  
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synthetic biology
Novel protein as 
biocatalyst or drugs 
Example: Strain development 
for amino acid production
Corynebacterium glutamicum Lysine: > 1.5 Mio. t/y
E. coli
Problem: Allosteric feedback inhibition
Example: Aspartokinase (lysC)
 catalyse the first and limiting   
step of synthesis of aspartate  
family amino acids
Glucose
8 Lysine
Allosteric inhibition   
A general problem limiting 
product yield and titer in 
many industrial 
bioprocesses!
How to combat allosteric inhibition?
Lysine
Traditional view of allostery: Binding of an effector 
and conformational change of the enzyme
Solution:
Mutation of the enzyme to avoid effector binding !
Random mutation over 50 years 
identified 6 (reported) targets for lysC
 Random Mutation: e.g. UV-Light, X-ray
 Selection:  Analoge Chemicals, Auxotrophic
Time-consuming and many other disadvantages!
Patenting
Conventional approach identified mainly 
mutations on the protein surface 
x
x
x
Inhibitor
x
x
Our new approach:
To identify and modify the 
signal transduction pathway 
x
x
x
Substrate
Key: 
To find the residue-residue 
interaction network
of conformational change
Z. Chen et al. Appl. Environ. Microbiol. 2011; Z. Chen et al. J. Biotechnol 2011
Targeted molecular dynamic simulation
Conformational change 
of lysC upon binding of 
lysine
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Mapping the patterns of atomic motion
to dynamic residue interaction network
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Correlated coefficient matrix
MD with
effector
Co-evolutionary analysis is also  
very useful to study allostery
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Conservation of residues 
Correlated mutations
-Structurally or functionally relevant
-Adopted to import new function or regulation
S315
H320V347
E346
S345
T344
R416
N414
F405
M318
Evolutionary and MD analyses revealed 
signaling network of AK3 at atomic level
Targets
All the previous 6 mutations from the last decades also found!
M251
T253
R305
I392
V339
S338 I337
T355
T352
F329
L325
F324
G323
V349M417
N426
C428
S423
S424 C378
Z. Chen et al. J. Biotechnol. 2011 
30 mutations predicted and experimentally 
confirmed with reduced feedback inhibition
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1.2 Wild-type
Predictions also applied to 
aspartokinase from C. glutamicum
1.4 Mutant N372A
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Wildtype vs. point mutation of lysC for 
lysine production in C. glutamicum
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growth!
From „zero to hero“ with a single 
mutation and in a minimal medium
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Systematic rational design of pathways
Enhance precursor availability
G35
T36
K37
NADP
Increase NADPH supply
On the way beyond 150 g/L by design in short time!
Chen et al. J. Biotechnol. 2011; AEM. 2011; Geng et al. AMB, 2012,  Zeng et al. Patent applications
R441
E443
E417
T365
E240
Y238
R281
L286
Reengineering of threonine deaminase 
for theronine production in E.coli
21L. Chen et al. Appl Microb Biotechnol 2012 
ACT ACT
Threonine
(B)
Redesign of homoserine dehydrogenase
Natively inhibited by threonine
Design based on predicted allosteric signal transduction 
R441
E443
E417
T365
E240
Y238
R281
L286
between catalytic domain and regulatory domain
Substrate
(Glucose)
M
Cell growth/
Byproducts
Synthetic protein for dynamic and self-
regulation of biosynthesis 
Needed only in the 
cell growth phase of 
a fermentation
hom Thr
Product
(lysine)
Intracellular
product as signal
Artificial 
allosteric control
Poster 4 . Chen et al.
Modular design of artificial enzyme
Sensor domain
Control domain
 Redesign of signal molecule binding sites in the sensor domain
 Identify the (allosteric) signaling pathway
 Protein-protein docking to predict domain-domain interaction mode
 Design of specific linker to provide potential domain interface
 Combination of rational design with directed evolution
Interface
New concept for protein design: From 
structure via dynamic modules to function
Equilibrium 
Dynamics
Non-equilibrium 
Dynamics
Conformation Energy 
Time
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n
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r
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C. Ma. PLoS ONE 6(10): e26453. 2011
C.Ma. PLos One 7(2):e31529, 2012
C. Ma et al. Submitted. 2012 
Distribution DissipationMD simulation
Poster 191 Ma and Zeng. New Concept and Algorithms to Reveal 
Protein Dynamics and Intramolecular Interaction Network and 
Their Application for Protein Design 
Energy dissipation of key residues in AK3
26
From structural to dynamic modules 
revealed by the new method
27
Synthetic AK3 for response to
different effectors
Design of non-native lysine responsive HSD
• The integration of MD and evolutionary analysis is a 
powerful and predictive appraoch for the re-design 
of allosteric regulation of enzymes of amino acid 
systhesis.
– For three different aspartokinases from E.coli and C. glutamicum
30 efficient mutation points have been successfully identified 
and experimenally verified.
Summary
• Systematic structure-based design led to highly 
productive strain of L-lysine in a very short time.   
• Synthetic protein designed for dynamic and self-
regulation of biosynthesis 
– New concept and algorithms for protein dynamics developed
• Structure-based design provides new possibilities 
for a rational development of biocatalysts.     30
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4. Transport process
3. Signaling 
process 
Effector
Perspective: Structural ME and SynBio  
S
Scaffold protein
P
2. Enzymes        
& pathway 
e.g. allosteric regulation 
Regulator
1. Genetic circuits
DNA
RNA
(e.g. riboswitch)
Chen et al. (2010) TIB, 28, 534
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